This article was originally published in The Gray Sheet
Executive SummaryNames David Tholen president, chief operating officer and member of the board and its executive committee, effective June 1. Tholen previously was vice president and general manager of Abbott Lab's diagnostics division. Former Murex President C. Robert Cusick, who for seven months has been acting COO, remains at the diagnostic products firm as CEO and vice chairman, a newly created position.
You may also be interested in...
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.